We describe here an autoradiographic method to measure the in vivo rate of serotonin synthesis in rat brain. The method is based on the use of the L-tryptophan analogue a-methyl-L-tryptophan (a-MTrp), which is con verted in vivo into a-methyl serotonin (a-M5HT). Since a-M5HT is not a substrate for monoamine oxidase, it is accumulated in the brain tissue. Data are presented to confirm time-dependent conversion of a-MTrp into a-M5HT in the dorsal raphe nucleus and also in the pineal body, an organ outside the blood-brain barrier. It has also Several methods have been proposed to measure serotonin synthesis in the brain of laboratory ani mals (for review, see Haber et aI., 198 1; Korf, 1985). Two approaches have been used, i.e., steady state and non-steady state. The rate of serotonin synthesis has usually been estimated on the basis of changes in the concentration of tryptophan metab olites [5-hydroxytryptophan, 5-hydroxytryptamine, or 5-hydroxyindoleacetic acid (5HIAA)] after some kind of pharmacological manipulation. Serotonin (5-hydroxytryptamine) is synthesized from L tryptophan in a two-step enzymatic process. The first step, hydroxylation of L-tryptophan with tryp tophan 5-hydroxylase (EC 1. 14. 16.4), requiring tet rahydrobiopterin as a co-factor and molecular oxy-
1 been shown that washing brain slices in 10% trichloro acetic acid results in <3% incorporation of a-MTrp into brain proteins. The rates of synthesis are calculated in several grossly dissected brain structures by using tracer kinetics and a three-compartment biological model. The half-life of the precursor pool is estimated to be -20 min. The rate of serotonin synthesis is highest in the pineal body. Key Words: Biological model-a-Methyl L-tryptophan-a-Methylserotonin-Ra t brain Serotonin synthesis rate.
gen, is generally accepted as the rate-limiting step (Moir and Eccleston, 1968) . The product, 5-hydroxY-L-tryptophan, is decarboxylated by aro matic amino acid decarboxylase (AAAD; EC 4. 1. 1.28), an enzyme present in several types of brain neurons and active also in decarboxylation of other aromatic amino acids. Unlike AAAD, tryp tophan hydroxylase is located only in serotonergic neurons (Kuhar et aI., 1972) .
The in vivo rate of serotonin synthesis depends on several factors, mainly, the concentration and activity of tryptophan hydroxylase and the concen trations of the substrate (L-tryptophan), endoge nous pteridine co-factor, and molecular oxygen. Because these factors are interdependent, an in vivo estimation of serotonin synthesis is the only measure with biological significance. Measure ments made to date fall into two categories. The first type makes use of a pharmacological treatment of the experimental animals to accumulate an en dogenous product whose concentration is consid ered to reflect the ongoing synthesis of serotonin. These methods can be criticized on the grounds that any feedback in the synthetic pathway is eliminated by the drug used, thereby distorting the results. The second category of measurement is represented by techniques involving radioactively labeled tryp-tophan. The disadvantage of labeled tryptophan is the necessity of chemical separation of metabolites and removal of the part of the tracer incorporated into proteins (Lin et aI., 1966; Costa and Neff, 1970; Neff et aI., 1971; Lane et aI., 1977; Tracqui et aI., 1983) . Another problem with the use of radioac tively labeled tryptophan as a tracer is the very fast removal from the brain of 5HIAA, the terminal me tabolite of the neurotransmitter serotonin. Never theless, the biochemical data collected thus far by these techniques have given us valuable, if not pre cise, information on serotonin synthesis and the in fluence of certain drugs on the rate of this synthesis. The effect of many of the drugs on other brain neu rotransmitters, especially catecholamines, makes the interpretation of data and a quantitative conclu sion more difficult.
To overcome these problems, we have used an analogue that may have better metabolic character istics than the natural substrate. This type of sub stitution was used successfully by Sokoloff et al. (1977) in the development of the deoxyglucose method, where the metabolic characteristics of the tracer are more suitable for quantification than those of the tracee (glucose). a-Methyl-L tryptophan (a-MTrp) is a tryptophan analogue that follows the metabolic pathway of tryptophan, being converted into a-methylserotonin (a-M5HT) (Sourkes, 1971) . Since the latter is not a substrate for monoamine oxidase (MAO; EC 1.4.3.4), it is accumulated in the tissue (probably in the neurons) and does not leave the brain for quite some time (Madras and Sourkes, 1965; Sourkes, 197 1; Rob erge et aI., 1972; Missala and Sourkes, 1988) . Re cently, Missala and Sourkes (1988) have presented data suggesting that a-M5HT can replace serotonin functionally, at least in respect to the transneuronal regulation of adrenal tyrosine hydroxylase activity.
In this and the companion article (Nagahiro et aI., 1989b) , we present the theoretical basis for this bi ological model, along with some data for normal rat brain (Part I) and a set of experiments indicating that we are able to assess changes in the rate of serotonin synthesis (Part II) using 14 C-Iabeled tracer and autoradiography. This is the first time that se rotonin synthesis has been assessed with very high anatomical resolution in living brain.
THEORY
The biological model is schematically repre sented in Fig. 1 . This is a three-compartment model, essentially equivalent to the 2-deoxyglucose model of Sokoloff et al. (1977) . The first-order rate constants (transfer coefficients) represent pro cesses for transfer from plasma to brain (Kf; mIl glmin) and back (k1; min-I ), and for conversion of a-MTrp into a-M5HT or the transfer of a-MTrp into an irreversible compartment (kj; min -I). It is gen erally accepted that the rate-limiting step for sero tonin synthesis is hydroxylation of L-tryptophan by tryptophan hydroxylase, an enzyme found only in serotonergic neurons. We assume that the same process is the rate-limiting step in the conversion of a-MTrp into a-M5HT because very little 5-hydroxy-a-methyl-L-tryptophan is found in the brain tissue (T. L. Sourkes, unpublished results).
However, kj does not have to represent the rate of hydroxylation of a-MTrp; it could represent any step after which a-MTrp cannot return to the "precursor" pool. The Kf (Fig. 1) actually repre sents the first-order rate constant kf (min -1 ) multi plied by the plasma volume in a weight unit volume of the brain (Gjedde, 1982) . A set of homogeneous differential equations representing tracer movement between compartments ( Fig. 1) can be written as reported before by Sokoloff et al. (1977) . The set of these differential equations can be solved by several different methods (Ritger and Rose, 1968) . With the initial conditions C�(O) = 0, Ct.(O) = 0, the solution of the system after rear rangement yields Eq. 1 (Sokoloff et aI., 1977; Phelps et aI., 1979; Kato et aI., 1984; Evans et aI., 1986) :
The symbol ® represents an operation of the con volution. C;(t) represents the total plasma tracer concentration as a function of time and C7(1) is the total tissue tracer concentration at time T. The ft, represents the fraction of free tracer present in the plasma. (Part of the tracer is bound to the plasma proteins.) It is well known that not all plasma tryp tophan is available for transport to the brain precur sor compartment (Fernstrom and Wurtman, 1972; Gessa and Tagliamonte, 1974; Fernstrom et aI., 1976; Pardridge, 1977; Sarna et aI., 1985) . The case of a-MTrp is similar. The fraction of total plasma tracer ft, available for transport to the brain is as sumed to be constant during the experiment. This fraction can be easily measured in a few samples by filtration through an Ultra-free-MC filter (cat. no. UF3LGCOO; Millipore of Canada Ltd.). A nonlinear least-squares fitting of measured brain tissue tracer radioactivity obtained in rats af ter different circulation times or in positron emis sion tomography (PET) scans taken at various times after tracer injection to that predicted by Eq. 1, with arterial plasma tracer concentration [C*(t)] as an input function, would yield the values of the trans fer coefficients.
When the vascular compartment correction is in cluded, the tissue concentration of the tracer is A7(1) = C7(1) + Vp . C;(1) (2) Equation 2 was used in the estimation of K* [K* = (Kj . kj)/(ki + kj)] and the half-life of the precur sor pool [= In2/(ki + kj)] employing an optimiza tion algorithm. Since individual rate constants are estimated with quite large errors, and the fraction of the tracer in a precursor pool is large, the use of the full operational equation (Sokoloff et aI., 1977) is not practical unless the experiment is of long dura tion and regional rate constants are known. It can be shown that the constant K* is related to the rate of serotonin synthesis by Eq. 3, just as it was in the deoxyglucose model related to the glucose utiliza tion (Phelps et aI., 1979; Kato et aI., 1984; Redies and Diksic, 1989) :
K* can also be estimated as a tangent to the curve of the volume of distribution as a function of ® (see Fig. 3 Table 1 ). Because of this, the absolute value of the synthesis rates presented in Table 5 and calculated with the LC estimated from ratios given in Table 1 (Bloxam and Curzon, 1978; Anderson, 1979) . Tryptophan also competes with other branched chain and aromatic amino acids for the same carrier (Pardridge, 1977; Yuwiler et aI., 1977) . Since our animals were deprived of food for � 18 h, the plasma amino acid concentrations were relatively constant. It is also assumed that the ratio between plasma free tryptophan and other amino acids com peting for the same carrier is stable and would not appreciably vary from animal to animal. (This has been confirmed in separate experiments to be pub lished.) It has been suggested that this ratio is the most important single factor determining brain tryp tophan concentration (Fernstrom and Wurtman, 1972; Bloxam and Curzon, 1978; Anderson, 1979) and is a determining factor in the rate of serotonin synthesis. On this basis, the plasma free tryptophan concentration was used in the calculation with Eq. 3. "Preconditioning" by food deprivation will make the ratio of the plasma free tryptophan to the sum of other amino acids sharing the same carrier more or less constant, and the ratio should not vary substan tially from animal to animal. If there is a substantial variation in plasma tryptophan concentration, a "normalization" of data from different animals can be done by using Eq. 3 given in Nagahiro et al. (1989b) in the estimation of the constant �p (�p = K* . C p )' This procedure reduces the influence of animal to animal differences in plasma tryptophan on the slope and hence on the estimate of the rate of serotonin synthesis; it also permits a proper weight ing of data from different animals.
As mentioned above, the conversion of tissue tracer into metabolite (a-M5HT) is a rather slow process. Consequently it is necessary to subtract a large precursor pool from total tissue radioactivity. In other words, the relative amount of tracer enter ing the metabolic compartment is small. This fact makes the full operational equation (Sokoloff et aI., 1977; Kato et aI., 1984) very sensitive to the abso lute values of the rate constants, and its utility is very limited in estimating the rate of serotonin syn thesis when the regional rate constants are not known. However, from these data (tissue time distribution volume) we have been able to estimate the half-life of the precursor pool, the quantity needed in the further development of the method (companion article). The method will be applicable to PET scanning where the entire time-radioactivity curve is obtained in the same patient, allowing de termination of the regional rate constants from the fit of Eq. 2 to the experimental data. Our prelimi nary results support this (Diksic et aI., 1987 (Diksic et aI., , 1988 .
To avoid the need for regional rate constants and to make the autoradiographic method more practi cal, we have devised a protocol in which only the slope of an irreversible tissue tracer trapping is de termined. This is the only variable required if the synthesis rate is going to be estimated (see above) and theoretically calls for a minimum of two time points, with the tissue precursor pool reaching or exceeding a transient equilibrium with the plasma (supply) compartment. From our first set of exper iments, where the entire tissue time-radioactivity curve was measured (Fig. 3) , it was possible to es timate that the half-life of the precursor pool is �20 min (Table 4 and Fig. 3 ). On this basis, a two-time point protocol, described in detail in the companion article, has been devised. In this protocol rats are killed at 60 and 150 min after tracer injection. (The first point is represented with 0 "" 100 min in Fig.  3 .) The first point is selected to be about three to four half-lives of the precursor pool (reaching close to 90% of a transient equilibrium).
METHODS

Radiopharmaceuticals and animals
For the first set of experiments, U-[14C]MTrp was syn thesized by the method we described for IIC-Iabeled com pounds (Chaly and Diksic, 1988) using e4C]CH31 sup plied by ICN Radiochemicals (Irvine, CA, U.S.A.). The specific activity of that material was 50 mCi/mmol, and the radiochemical and chemical purity was >98%. The enantiomeric purity for the radiopharmaceutical was de termined by analysis on a CHIROPAC WH column (J. J. Baker, Phillipsburg, NJ, U.S.A.) [details given in Chaly and Diksic (1988) ]. The compound was at least 98% L enantiomer as judged from the HPLC chromatograms. The second set of experiments was carried out with the J Cereb Blood Flow Metab, Vol. 10, No. 1, 1990 radiopharmaceutical having a specific activity of 55 mCii mmol prepared by E. I. Du Pont de Nemours and Co., (Boston, MA, U.S.A.). The chemical, radiochemical, and enantiomeric purities were reported by the supplier and confirmed by us to be >96%.
The animals used in these studies were female Wistar rats weighing between 190 and 220 g. They were housed in our animal facility (room temperature 22°C) for at least 3 days before being used in an experiment. The animals were provided with food (Rat Chow 5012; Purina Mills, St. Louis, MO, U.S.A.) and water ad libitum and were kept on a regular day-night cycle (7 a.m. to 7 p.m. light). The night before the experiment, the rats were fasted but water was provided ad libitum. All the rats were killed between noon and 2 p.m.
General procedure
In rats under light halothane anesthesia (1-1.5%), the femoral artery and vein were catheterized with aP E-50 polyethylene catheters. The animals were placed in loose fitting plaster casts (Sako et aI., 1984) and allowed to wake up. Physiological values, arterial pH, Paco2, Pao2, blood pressure, hematocrit, and rectal temperature were measured before the beginning of the experiment. Hema tocrits were also measured at least three more times dur ing the experimental procedure. The body temperature was kept at �37°C with a 100-W lamp. The rats were awake � 2 h before being injected with the tracer. At the end of each experiment, the animals were killed by de capitation and the brain removed, usually within 1.5 min. The brain was placed on a block of dry ice and seven structures removed (gross dissection): frontal and parietal cortex, caudate nucleus, hippocampus, thalamus, hypo thalamus, midbrain, and pons. In addition, the pineal gland was also removed as a separate sample. Tissue specimens were weighed and dissolved in Protosol (E. I. Du Pont de Nemours and Co.). After dissolution, a liquid scintillation cocktail was added (10 m!) and radioactivity measured. After correction for efficiency, the radioactiv ity was expressed in nanocuries per gram of tissue.
Twenty-six rats received 10 ILCi of U-[14C]MTrp in jected as a I-min bolus. They were then killed at 1, 5, 10, 20, 40, 60, 80, 100, 120, 150 , and 180 min after the begin ning of the tracer injection. Twelve to 15 20-ILI plasma samples were taken at each time interval. The plasma was deproteinized with 15 ILl of 20% trichloroacetic acid (TCA). After mixing the plasma and spinning it for �2 min at 12,500 g, 20 ILl of supernatant was taken for the radioactivity determination by a liquid scintillation count ing method. In addition to these samples, two samples were taken for determination of plasma tryptophan by the HPLC method.
Plasma tryptophan determination
Total plasma tryptophan was determined by the HPLC method of Krstulovic and Matzura (1979) , as used previ ously (Missala and Sourkes, 1988) . The fraction of free (i.e., none albumine bound) tryptophan in the plasma was measured in a separate set of rats by filtering 50 ILl of plasma through an Ultrafree-MC filter (cat. no. UF 3LGCOO; Millipore Canada Ltd.) with 10,000 MW cutoff point. Since the fraction was found to be fairly constant, we elected to use an average value for the fraction of free plasma tryptophan to calculate the plasma free tryp tophan concentration needed in our analyses.
Sampling of dorsal raphe nucleus for HPLC
Eight rats were killed at 1 and 2. 5 h after the start of the injection of o:-e4C]MTrp (50 !LCi). The experimental pro cedure, except for cutting frozen brain in the cryostat, was the same as described above. The brainstem, includ ing the dorsal raphe nucleus, was sectioned coronally and serially at 40-J-lm thickness, and the sections were mounted on glass slides. The opposite side of the mount surface of the glass slide was warmed slightly by fingers in the cryostat so that the sections adhered to the glass. With the aid of a surgical microscope, the dorsal raphe nucleus just ventral to the aqueduct was punched out (Fig. 2) with a 20-G blunt needle (inner diameter 0. 56 mm; outer diameter 0. 89 mm), from the 30--4 0 sections per rat in the cryostat. The needle was connected to a I-ml sy ringe and the tissue in the needle was blown out into plastic tubes. The punched-out tissues from the four rats at each time point (four at each time; 1 and 2. 5 h) were put together into preweighed tubes. The tubes containing the nucleus raphe dorsalis obtained from four rats was weighed immediately and stored at -70°C until HPLC analysis was done.
Sampling of the pineal body for HPLC Three rats were used for 2 and 2.5-h experiments. Rats were killed at those times after injection of 50--60 !LCi of o:-e4C]MTrp. After the brain was removed, the pineal body was gently picked up by forceps. Pineal bodies from three rats at each time point were put separately into the preweighed vials and weighed. The tissues were stored in the deep freezer until HPLC analysis was done.
Dorsal raphe and pineal body HPLC analysis
Tissue samples of dorsal raphe and pineal body were homogenized in 3 vol of 0. 4 M HCl0 4 containing 0. 1% ascorbic acid, and the supernatant fraction was analyzed by HPLC (Missala and Sourkes, 1988) after addition of o:-MTrp, o:-M5HT, and 5-hydroxy-o:-methyltryptophan as standards.
Determination of fraction incorporated into protein
To determine the fraction of o:-[14C]MTrp incorporated into protein in the brain, the cryostat sections were washed with cold Wc) 10% TCA. The 30-!Lm sectioned brain slices from a rat killed at 24 h after the tracer injec tion were mounted on microscopy glass and immediately dried. Sections were dipped in the bath containing cold 10% TCA for 30 min with gentle agitation of the bath. The sections were washed three times with TCA, rinsed twice with cold distilled water for 10 min, and dried. Adjacent brain sections were not washed. Both sets of slices were exposed to the same x-ray film for 3 weeks alongside polymer 14C standards.
LC estimation
The LC is the constant required to convert an estimate of the irreversible tissue uptake of a tracer into the rate of tracee utilization (conversion, metabolism) (Sokoloff et al., 1977) . It is actually a conglomerate of several other constants, similar to the LC for the deoxyglucose method described by Sokoloff et al. (1977) :
where V m and Km are Michaelis-Menten constants for tracer (with asterisk) and tracee and X. is equal to the ratio of the volumes of distribution for the tracer and tracee {X.
Several measurements of the Michaelis-Menten con stants for tryptophan hydroxylase, with tryptophan as a substrate, are given in the literature. Unfortunately, not all of them were obtained with the same co-factor. To minimize introduction of an error into estimated LC, we have calculated the ratios of Km and V max from different measurements (Table 1 ). An average value for the ratio of Km/V max for tryptophan as substrate is 10.3 ± 2.9; with o:-MTrp it is calculated to be 49. 8 (Table 1) . As mentioned above, the ratio between the volumes of distribution for the tracer and tracee is also needed to estimate LC. An average value for this ratio was estimated from data of Missala and Sourkes (1988) , where plasma and brain con centrations were measured in the same animals (rats) for both amino acids. From these data, the average value for the ratios between vt and V D (X. = vt/V D) is estimated to be 2.21 ± 0.23 (mean ± SD). Substitution of these values into Eq. 4 yields an LC of 0.46. Since this LC is calculated from measurements of several authors, we did not estimate an error for it.
lt is reasonable to assume that the LC is uniform over the whole brain. This assumption is based on the notion that the constants will change from structure to structure, but the ratio between them will not. On evaluation of Eq. 4 this seems reasonable, especially when the LC is con sidered as the ratio of K* for tracer and K for tracee. The LC (Eq. 4) could also be expressed as a ratio of K* and K (tracee) (Redies and Diksic, 1989) . Since the incorpora tion of L-tryptophan into proteins is substantial, it is not surprising that its volume of distribution is smaller than that for the tracer, which has a very small protein incor poration (Madras and Sourkes, 1965; present article) .
An alternative way to estimate the LC is to compare the unidirectional rate of the tracer trapping (K*) and the net rate of tryptophan hydroxylation (K), as was done by Gjedde (1982) and by Redies and Diksic (1989) in the deoxyglucose model. Measurements of the LC using this approach are presently underway. 
Parameter optimization
To be able to evaluate other than the least-squares ob jective function, we elected to apply optimization algo rithms based on the Gauss-Newton method (Forsythe et ai., 1977) . We used BARD and BSOLV algorithms (Kuester and Mize, 1973) with constraints. The con straints used were those requiring a positive value for parameters (rate constant or transfer coefficients).
In a least-squares optimization, we need to find a set of parameter values that minimize the differences in weighted sums of squares (S) between the observed tissue volume of distribution (Vo) and the calculated tissue vol ume of distribution (Ve), or, in mathematical notation, min S = I Wi(Vo -VJ2, where Wi is the weighting factor. The optimization routine permitted us to evaluate another objective function where the total absolute dif ferences, min S = I wilVo -Vel, were minimized. Other objective functions could also be investigated when an optimization approach is used (Lam, 1981) . We had also evaluated different weighting functions, namely, Wi = 1, Wi = J/Vo, Wi = lIV�, Wi = liVe' and Wi = lIV�. These weighting factors are used rather than some kind of weighting based upon the error in each point because of the difficulty in obtaining a reliable error estimate for each datum point. However, a detailed analysis of results obtained with different weighting factors will not be pre sented in this article. Here we can say only that the least squares or absolute value objective function produced an equally good fit to our data as judged on the basis of F statistics. Our data were always best fitted by using Wi = lIVo; however, the fit was only slightly better than for Wi = 1. To ensure that the minimum was reached, the HES SIAN matrix was evaluated at the minimum. Only solu tions with the positive HESSIAN matrix were accepted (Forsythe et ai., 1977) .
RESULTS
The average values for physiological parameters of rats used in this study are given in Table 2 . There are no significant differences between the values for rates used in the kinetic measurements and those in the HPLC analysis in the dorsal raphe nucleus. To illustrate the position of sampling in Fig. 2 , an au toradiogram of the brain slice from which the dorsal raphe nucleus was removed by micropuncture is 43 .3 ± 1.9 43.6 ± 2.5 Plasma total tryptophan (nmol/ml) 52 ± 17 47 ± 11 a n = 8 for dorsal raphe and n = 6 for pineal body sampling experiments. shown. The absence of the intensely labeled struc ture of the dorsal raphe is clearly apparent when this autoradiogram (Fig. 2) is compared with one taken at the same level ( Fig. 1 in Nagahiro et aI, 1989) . In our attempt to obtain information on in vivo conversion of the tracer into a-M5HT, we have analyzed for the presence of the tracer and its me tabolites in this structure and in the pineal body, i.e., the regions with the highest concentrations of serotonin (see Methods for details.). The results of the HPLC analysis presented in Table 3 reveal that 31 and 45% of the total radioactivity is present as a-M5HT in the dorsal raphe nucleus at 60 and 150 min, respectively, after injection of the tracer. In the pineal body, 88% of total radioactivity was present as a-M5HT at 150 min after injection. At the same time, the amount of radioactivity present in the acid-precipitable fraction was assessed. The incorporation into proteins was very small, <2%, a finding similar to that reported earlier by Madras and Sourkes (1965) for liver.
The value of the half-life of the precursor pool and that of K* given in Table 4 were estimated by a least-squares minimization procedure as described Total radioactivity represents a su m of a-MTrp , 5-hydroxy tryptophan , and a-M5HT. Ti ssue samples were col lected from four rats at each time point in dorsal raphe analysis and from three rats in pineal body analysis. 1.8 ± 0.8 1.8 ± 0.6 2.0 ± 0.8 1.8 ± 0.9 1.7 ± 0.8 1.8 ± 0.6 2.0 ± 0.6 49 ± 3
Individual rate constants are not given because their individual values are uncertain. The half-life of the precursor pool was calculated as In 2/(ki + kj). The only reliable variable estimated from this data set is K* = Kj . kj/(ki + kj) (see text for detailed discussion). The K* is given as an estimate obtained from an optimization routine ± an error estimated from the variance covariance matrix.
above. Examination of the correlation matrix re vealed that all rate constants are highly correlated. Experimental rat data can be fitted to Eq. 2 with various combinations of the rate constants; in other words, there is no unique solution. However, al though the rate constants may differ, K* is always very similar. Since the absolute value of these rate constants is not useful in the serotonin auto radio graphic model, as mentioned above, the value of K* or �p (Kcp = K*' C p ) must be considered the only variable reliably estimated this procedure. It should also be emphasized that K* [K* = (Kj . kf)/ (ki + kj)] is the only variable that can be used with confidence and assigned a biological meaning. However, from the evaluation of the rate constants, we were able to obtain estimates of the precursor (Fig. 3) also indicates that at -60 min (exposure time 0 = 100 min) the tracer is reasonably close to the apparent steady state (about three half-lives of the precursor pool). This agrees well with the estimate of the half-life of the precur sor pool (-20 min) as estimated from Eq. 1. The rates of serotonin synthesis estimated by this method in a few structures of grossly dissected brain tissue are compared with the rate found in the literature in Table 5 . The published values have been averaged whenever several measurements for the same structures have been found (see Table 5 footnotes). We are aware that this comparison is questionable because there are certainly different amounts of other tissues present in samples from different investigators. Moreover, our values were calculated with an average value for the plasma free tryptophan fraction. This fraction was determined in a separate set of animals of approximately the same age and weight as used in the "rate" experi ments and kept in our laboratory under the same conditions. The plasma free tryptophan fraction used in this calculation was 20 ± 2% (A. Takada and M. Diksic, unpublished), a figure that agrees well with measurements reported from other labo ratories (Chaouloff et aI., 1986) . In the companion article describing a study using an autoradiographic method, we present the rate of synthesis for addi tional structures (Nagahiro et ai. 1989b) . When the same analysis as the one described there was re peated by using only rats killed after 60 or 70 min and individual plasma free tryptophan concentra tions, slightly different rates of serotonin synthesis The rates are given as pmol/g/min. For structures where more than two measurements were found, averages were calculated with an equal weighting assigned to individual results and are given as an average ± SD. When only one measurement was found and the authors reported error, their error is given as SD. In the case of two measurements, only the mean is given.
a The rates of serotonin synthesis were obtained using LC = 0.46 (see text), K* given in Table 4 , and an average concentration of plasma free tryptophan in individual rats. Rates are given as an estimate ± error derived for uncertainty in K* (Table 4) .
b Lovenberg et al. (1967) . c Tappaz and Pujol (1980) , Chaouloff et al. (1985) , and Neckers and Meek (1976) .
d Tappaz and Pujol (1980) and Colmenares et al. (1975) . e Tappaz and Pujol (1980) and Chaouloff et al. (1985) . f Chaouloff et al. (1985) . g Neckers and Meek (1976) .
were obtained that were, however, not significantly different from those given in Table S . Incorporation of the tracer into brain proteins is also illustrated by the autoradiograms in Fig. 4 . It can be seen that the amount of radioactivity left after washing the brain slice with 10% TCA (Kirikae et aI., 1989 ) is <2% of any integrated brain structure (an example for the raphe nucleus is shown in Fig. 4 ).
DISCUSSION
The method described in this article provides ba sic data for an in vivo autoradiographic measure ment of the rate of serotonin synthesis in the brain of living laboratory animals. The method does not require any pharmacological manipulation or bio chemical separation, nor does it influence any post mortem artifact. A very attractive feature of this procedure is the use of an analogue of tryptophan, a-MTrp, which is a substrate for tryptophan hy droxylase, a catalyst in the conversion of L tryptophan to serotonin (Gal and Christiansen, 1975) . A major advantage of this analogue is that its final metabolic product, a-MSHT, unlike serotonin, is not a substrate for MAO and is consequently trapped in the brain tissue. Diffusion of a-MSHT through the blood-brain barrier back into the circu lation or into the CSF can be neglected, just as for serotonin itself. In our own tests we have found in the CSF <2% of the total brain radioactivity in two animals killed 120 min after injection of tracer (un published result). The principle of an irreversible trapping of a me tabolite is the one used by Sokoloff et al. (1977) in their development of the deoxyglucose model, where 2-deoxyglucose-6-phosphate is formed. It has been shown that a-MSHT formed in vivo from a-MTrp can take the place of serotonin (Roberge et aI., 1972) and recently that a-MSHT can assume the function of its naturally occurring congener, sero tonin (Missala and Sourkes, 1988) . The latter con clusion was drawn from the influence of a-MSHT on adrenal tyrosine hydroxylase activity (Missala and Sourkes, 1988) . Experiments currently under way indicate that a-MSHT found in the brain of rats after they have been given a-MTrp parenterally is present in synaptosomes (Montine and Sourkes, 1989) . Our preliminary results also indicate that a-MSHT can be released from tissue slices on de polarization by potassium (E. Hamel et aI., unpub lished).
Past methods for the measurement of the rate of serotonin synthesis (turnover) required the use of drugs to induce inhibition of a particular enzyme or to block the transport of 5HIAA from the brain. However, such drugs often have multiple effects in the brain. For example, MAO inhibitors not only block oxidation of monoamines but also reduce se rotonin synthesis (Macon et aI., 197 1) and increase brain tryptophan (Tagliamonte et aI., 1971) . The 5HIAA transport blocking agent (Werdinius, 1967) probenecid also has an effect on brain and serum tryptophan (e.g., Korf et aI., 1972) . The disadvan tage of such drugs is that they affect the steady state metabolism of tryptophan. All in all, these methods give similar rates of serotonin synthesis, with values in whole rat brain varying between 16.7 and 41.7 pmollg/min (Korf, 1985) , depending upon which inhibitor has been used. The steady-state methods using radioactively labeled tryptophan yield a rate of synthesis between 25 and 31.7 pmol/ g/ml (Korf, 1985) in whole rat brain. These methods are probably closer to the present techniques than are the pharmacological manipulations mentioned above. However, they require separation of metab olites and, because of this, are time consuming and not very practical. Data presented in this and the companion article cannot be directly compared to the whole-brain rate of synthesis because we mea sured only grossly dissected structures.
The method described here has aimed at main taining the natural substrate, L-tryptophan, in a steady state and employing the analogue in trace amounts to apply tracer kinetics as described in Theory. The specific activity of the tracer used was between 50 and 55 mCi/mmoI. In the kinetic exper iments described, we used 10 fLCi of the tracer (spe cific activity 50--55 mCi/mmol); i.e., we have in jected between 182 and 200 nmol of tracer over a I-min period. The maximum amount of tracer at tained in plasma was �250 nCi/ml plasma. Convert ing this into concentration, it can be seen that the plasma concentration was increased by � 5 nmol/ ml, which is � 10% of the total plasma tryptophan. But this increase lasted only a very short period of time, being reduced to about one-half (= 120 nCi/ml) 2.5 min after the end of injection. Even with this increase, combined plasma concentration of u-MTrp and tryptophan is far below the apparent Km (710 fLM) for the transport of tryptophan across the blood-brain barrier (Pardridge, 1977) . Since the transport is actually governed by the ratio of the free tryptophan to the sum of the large neutral amino acids, this increase would cause only a minute increase in the ratio, and for this short pe riod of time probably could not have an adverse effect on the steady-state metabolism of tryp tophan, especially in the brain.
The auto radiograms obtained at 24 h after injec tion (Nagahiro et aI., 1989a) in conjunction with the plots of the volume of distribution (Fig. 5 in that article) confirm one of the essential assumptions of the model: that loss of the tracer from the brain is negligible. Representative plots of volume of distri bution indicate that a tracer steady state is reached at �100 min of exposure time (Fig. 3) . (This expo sure time corresponds to �60 min clock time.) This is also in reasonably good agreement with the half life of the precursor pool, which has been estimated to be �20 min (Table 4 ) from the fit to Eq. 4. Since the tracer reaches an apparent steady state at �60 min, this time was selected as the first in the two time point method applied in N agahiro et al., (1989b) . As mentioned in Theory, it can be deduced from the plot of volume of distribution that the one time-point autoradiographic method is not suitable for the estimation of the serotonin synthesis rate and in this way differs from the Sokoloff et ai. de oxyglucose method (1977) . The main reason for our method not being suitable as a one-point autoradio graphic method is that a large fraction of the tracer is present in the precursor pool at a reasonable time of experiment (e.g., up to 180 min), and this must be subtracted from the total tissue radioactivity present at the kill time.
The rationale for using plasma free tryptophan as the concentration of tryptophan entering the oper ational equation is that the ratio between this value and the sum of other neutral amino acids (leucine, isoleucine, valine, methionine, tyrosine, and phe nylalanine) sharing the same carrier affects the brain tryptophan concentration (Yuwiler et aI., 1977; Sarna et aI., 1985) . Since our rats were de prived of food during the night before the experi ment, the concentration of amino acids in plasma was probably very constant. There are conflicting reports on the effect of overnight food deprivation on the rate of serotonin synthesis: Curzon et ai. (1972) reported no effect, whereas Perez-Cruet et ai. (1972) reported an increase.
The rats used in our experiments had the lower part of their body immobilized for � 3 h before the tracer was injected. Curzon et ai. (1972) reported an increase in the brain levels of 5HIAA after 3 h of immobilization and concluded that this results from increased serotonin turnover. This might explain in part the higher rate of synthesis found in some brain regions in the present work (Table 5) .
Tryptophan itself is a substrate for AAAD and yields tryptamine, with a Km of 3,000 roM (Loven berg et aI., 1962). The rate of tryptamine synthesis in the rat brain has been estimated at 4 pmol/g/min (Durden and Philips, 1980) . The AAAD Km value for a-MTrp as a substrate has not been measured; however, it has been shown that a-MTrp is a com petitive inhibitor of AAAD (Lovenberg et al. , 1962) . Thus, a 1 mM concentration of a-MTrp produced 50% inhibition of AAAD when tryptophan was used as a substrate. These authors also estimated that the relative specific activity of the AAAD isolated from guinea pig kidney is 5 for a-MTrp in comparison to 220 for tryptophan. From these data it is safe to conclude that only a very small amount of a-methyl tryptamine , as compared to the amounts of a-M5HT, would be produced in the rat brain during the course of the experiments described here. This assumption was indirectly confirmed by our HPLC results where no appreciable amounts of a-methyltryptamine were found. The HPLC analysis of the dorsal raphe nucleus and the pineal gland has also established that the tracer is converted into a-M5HT in vivo, thus con firming data reported earlier by Missala and Sourkes (1988) after intraperitoneal injection of macro amounts of a-MTrp. It is not surprising to see that the conversion in the pineal body is about twice as high as that in the dorsal raphe nucleus (Table 3 ; see also companion article). This differ ence agrees well with the biochemical measure ments where the average rate of serotonin synthesis in the dorsal raphe nucleus was 413 ± 118 pmoll g/min (Neckers and Meek, 1976; Tappaz and Pujol, 1980; Long et al., 1982; Donoroy et aI., 1985) and in the pineal gland 883 pmol/g/min (Lovenberg et al., 1967) . That rate for the pineal body compares fa vorably with the present estimate of 1,107 pmoll g/min (Table 5 ). (The rates of synthesis as measured by autoradiography are given in the companion ar ticle and should not be directly compared to those reported here, which we derived from gross tissue sampling.) The agreement of the synthesis rate in other structures (Table 5) is not as good. This could result from variable tissue sampling, in that material dissected by different investigators probably con tained different amounts of surrounding structures. Another source of variation may be the different pharmacological manipulations, e.g., inhibition of MAO, tryptophan hydroxylase, AAAD, or the acid transporter, used to obtain the biochemical data and performed on the assumption that there is no differ ential effect of drug on brain structures or on other transmitter systems that in turn might affect the rate of serotonin synthesis. It was also assumed that there is no feedback mechanism influencing the synthesis rate. Probably not all of these assump tions are justified (Schubert, 1974; Svensson et al., J Cereb Blood Flow Metab. Vol. 10, No. I, 1990 1975; Frankhuyzen and Mulder, 1982; Schlicker et aI., 1983; Trulson and Crisp, 1984; Wolf et al., 1985) , so that it would be unwise to compare these data with the present results.
The data provided here show a time-dependent conversion of labeled a-MTrp into a-M5HT (Table  3) , irreversible trapping of tracer, uptake in the structures known to contain serotonergic cell bod ies and terminals (Figs. 2) , and, in some brain struc tures, broad agreement of the serotonin synthesis rate with previous biochemical measurements (Ta ble 5). The method has great anatomical resolution (companion article), permitting us to measure the rate of serotonin synthesis accurately in many brain structures, including the differential influence of drugs on that rate. Finally, it lends itself to PET scanning, and preliminary results with a-MTrp la beled with II C (Chaly and Diksic, 1988) , a positron emitting radio nuclide , demonstrate the possibility of measuring the rate of serotonin synthesis in living brain (Diksic et aI., 1987 (Diksic et aI., , 1988 . As mentioned above, PET scanning has an advantage because the entire tissue time-radioactivity uptake curve is ob tained in the same subject. 
